Tesamorelin by Axiolabs - Visceral Fat Loss & Body Recomposition Peptide

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog designed to stimulate the natural production of growth hormone (GH) from the pituitary gland. It is widely studied for its ability to target visceral fat - the deep abdominal fat surrounding internal organs - making it one of the most unique peptides in metabolic and body recomposition research.

Unlike general fat loss compounds, Tesamorelin has been specifically associated with reductions in visceral adipose tissue, which is linked to metabolic health and overall body composition. By increasing endogenous GH levels, it influences fat metabolism while supporting lean tissue preservation.

Important medical note: Tesamorelin has specific medical applications in certain regions, but performance-related use should occur under professional supervision where legally permitted.

Visceral Fat vs Subcutaneous Fat

Not all body fat is the same. Visceral fat is stored around internal organs and is more metabolically active than subcutaneous fat (fat under the skin). It is also more resistant to traditional fat loss methods.

Tesamorelin has been studied for its ability to:
• Specifically reduce visceral fat stores
• Improve waist circumference and abdominal profile
• Support healthier fat distribution
• Influence metabolic markers related to fat storage

This targeted effect is what differentiates Tesamorelin from many other fat loss compounds.

Growth Hormone & Fat Metabolism

Growth hormone plays a central role in lipolysis - the breakdown of stored fat into usable energy. Tesamorelin stimulates GH release through the GHRH pathway, leading to increased fat utilization.

Key mechanisms include:
• Increased endogenous GH production
• Enhanced fat oxidation
• Support for lean muscle preservation
• Improved metabolic efficiency

Because GH also supports muscle retention, Tesamorelin is often associated with recomposition rather than simple weight loss.

Body Recomposition & Lean Physique

Body recomposition involves reducing fat while maintaining or increasing lean muscle mass. Tesamorelin has been studied for its potential to support this process through hormonal optimization.

Potential benefits include:
• Reduction in abdominal fat without muscle loss
• Improved muscle definition
• Enhanced metabolic balance
• Support for long-term physique improvements

For broader recomposition strategies, Tesamorelin is often discussed alongside peptides like Ipamorelin, which stimulates GH through a different pathway, and MOTS-c, which enhances metabolic efficiency at the cellular level.

Tesamorelin vs Other Fat Loss Peptides

Tesamorelin differs significantly from appetite-based fat loss compounds such as Semaglutide.

Key differences:
• Tesamorelin - targets visceral fat via GH stimulation
• Semaglutide - reduces appetite via GLP-1 receptor
• Tesamorelin - supports body recomposition

This makes Tesamorelin particularly relevant for users aiming to improve body composition rather than simply reduce calorie intake.

Comparison Table